<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>ProgRNA — RNA-Seq · RNA Therapeutics · Bioinformatics Tools</title><description>A technical journal for RNA-Seq, RNA therapeutics, bioinformatics tools, and AI-driven RNA research. Written by working bioinformaticians.</description><link>https://progrna.com/</link><language>en-us</language><item><title>Antibody-Drug Conjugates (ADCs): Design, Development, and Clinical Impact</title><link>https://progrna.com/blog/antibody-drug-conjugates-adc/</link><guid isPermaLink="true">https://progrna.com/blog/antibody-drug-conjugates-adc/</guid><description>Explore antibody-drug conjugates (ADCs) including linker chemistry, payload selection, approved ADCs, toxicity management, and their clinical impact in oncology.</description><pubDate>Sat, 11 Jul 2026 00:00:00 GMT</pubDate><category>rna-therapeutics</category><category>antibody-drug conjugates</category><category>ADC</category><category>oncology</category><category>biologics</category><category>targeted therapy</category><author>editors@progrna.com (ProgRNA Editorial Team)</author></item><item><title>AI in Pharmaceutical Research: Transforming Drug Discovery</title><link>https://progrna.com/blog/ai-in-pharmaceutical-research/</link><guid isPermaLink="true">https://progrna.com/blog/ai-in-pharmaceutical-research/</guid><description>Discover how AI and machine learning are transforming pharmaceutical research, from molecule generation to protein folding prediction and drug-target interaction modeling.</description><pubDate>Sat, 11 Jul 2026 00:00:00 GMT</pubDate><category>ai-rna</category><category>artificial intelligence</category><category>drug discovery</category><category>machine learning</category><category>pharmaceutical research</category><category>deep learning</category><author>editors@progrna.com (ProgRNA Editorial Team)</author></item><item><title>Biologics vs Small Molecule Drugs: Key Differences and Trade-offs</title><link>https://progrna.com/blog/biologics-vs-small-molecule-drugs/</link><guid isPermaLink="true">https://progrna.com/blog/biologics-vs-small-molecule-drugs/</guid><description>Comprehensive comparison of biologics versus small molecule drugs, covering manufacturing, immunogenicity, cost, administration routes, and clinical trade-offs.</description><pubDate>Sat, 11 Jul 2026 00:00:00 GMT</pubDate><category>rna-therapeutics</category><category>biologics</category><category>small molecule drugs</category><category>drug development</category><category>pharmaceutical manufacturing</category><category>biosimilars</category><author>editors@progrna.com (ProgRNA Editorial Team)</author></item><item><title>Biomarker Discovery and Validation: Methods and Applications</title><link>https://progrna.com/blog/biomarker-discovery-and-validation/</link><guid isPermaLink="true">https://progrna.com/blog/biomarker-discovery-and-validation/</guid><description>Comprehensive guide to biomarker discovery and validation methods, companion diagnostics development, regulatory framework, and clinical applications in drug development.</description><pubDate>Sat, 11 Jul 2026 00:00:00 GMT</pubDate><category>tools</category><category>biomarkers</category><category>companion diagnostics</category><category>drug discovery</category><category>precision medicine</category><category>clinical validation</category><author>editors@progrna.com (ProgRNA Editorial Team)</author></item><item><title>Clinical Trial Phases Explained: From Phase 0 to Phase IV</title><link>https://progrna.com/blog/clinical-trial-phases-explained/</link><guid isPermaLink="true">https://progrna.com/blog/clinical-trial-phases-explained/</guid><description>A comprehensive guide to clinical trial phases from Phase 0 through Phase IV, covering sample sizes, endpoints, regulatory requirements, and trial design principles.</description><pubDate>Sat, 11 Jul 2026 00:00:00 GMT</pubDate><category>rna-therapeutics</category><category>clinical trials</category><category>drug development</category><category>FDA</category><category>regulatory affairs</category><category>pharmacology</category><author>editors@progrna.com (ProgRNA Editorial Team)</author></item><item><title>CRISPR Gene Editing in Drug Discovery: Applications and Future</title><link>https://progrna.com/blog/crispr-gene-editing-drug-discovery/</link><guid isPermaLink="true">https://progrna.com/blog/crispr-gene-editing-drug-discovery/</guid><description>Explore CRISPR gene editing applications in drug discovery, from Cas9/Cas12 systems to off-target analysis and therapeutic breakthroughs in gene therapy.</description><pubDate>Sat, 11 Jul 2026 00:00:00 GMT</pubDate><category>ai-rna</category><category>CRISPR</category><category>gene editing</category><category>drug discovery</category><category>biotechnology</category><category>Cas9</category><author>editors@progrna.com (ProgRNA Editorial Team)</author></item><item><title>Drug-Drug Interaction Analysis: Methods and Clinical Significance</title><link>https://progrna.com/blog/drug-drug-interaction-analysis/</link><guid isPermaLink="true">https://progrna.com/blog/drug-drug-interaction-analysis/</guid><description>Comprehensive guide to drug-drug interaction analysis covering CYP450 system, pharmacokinetic and pharmacodynamic interactions, and clinical databases.</description><pubDate>Sat, 11 Jul 2026 00:00:00 GMT</pubDate><category>tools</category><category>drug-drug interactions</category><category>pharmacokinetics</category><category>CYP450</category><category>drug safety</category><category>clinical pharmacy</category><author>editors@progrna.com (ProgRNA Editorial Team)</author></item><item><title>Drug Formulation and Delivery Systems: Principles and Innovations</title><link>https://progrna.com/blog/drug-formulation-delivery-systems/</link><guid isPermaLink="true">https://progrna.com/blog/drug-formulation-delivery-systems/</guid><description>Comprehensive guide to drug formulation and delivery systems covering solid dosage forms, controlled release, nanomedicine, and bioavailability enhancement technologies.</description><pubDate>Sat, 11 Jul 2026 00:00:00 GMT</pubDate><category>tools</category><category>drug formulation</category><category>drug delivery</category><category>nanomedicine</category><category>controlled release</category><category>pharmaceutics</category><author>editors@progrna.com (ProgRNA Editorial Team)</author></item><item><title>Drug Repurposing Strategies: Finding New Uses for Existing Drugs</title><link>https://progrna.com/blog/drug-repurposing-strategies/</link><guid isPermaLink="true">https://progrna.com/blog/drug-repurposing-strategies/</guid><description>Explore drug repurposing strategies including computational approaches, clinical examples like sildenafil and thalidomide, and economic advantages of repositioning.</description><pubDate>Sat, 11 Jul 2026 00:00:00 GMT</pubDate><category>tools</category><category>drug repurposing</category><category>drug repositioning</category><category>drug discovery</category><category>computational biology</category><category>pharmaceutical economics</category><author>editors@progrna.com (ProgRNA Editorial Team)</author></item><item><title>Drug Target Identification Methods: A Comprehensive Guide</title><link>https://progrna.com/blog/drug-target-identification-methods/</link><guid isPermaLink="true">https://progrna.com/blog/drug-target-identification-methods/</guid><description>Explore modern drug target identification methods including genomics, phenotypic screening, and target validation techniques shaping pharmaceutical research.</description><pubDate>Sat, 11 Jul 2026 00:00:00 GMT</pubDate><category>tools</category><category>drug discovery</category><category>target identification</category><category>pharmacology</category><category>genomics</category><category>phenotypic screening</category><author>editors@progrna.com (ProgRNA Editorial Team)</author></item><item><title>FDA Drug Approval Process: A Step-by-Step Guide</title><link>https://progrna.com/blog/fda-drug-approval-process/</link><guid isPermaLink="true">https://progrna.com/blog/fda-drug-approval-process/</guid><description>Complete guide to the FDA drug approval process covering IND, NDA/BLA applications, accelerated approval, breakthrough therapy designation, and regulatory requirements.</description><pubDate>Sat, 11 Jul 2026 00:00:00 GMT</pubDate><category>rna-therapeutics</category><category>FDA</category><category>drug approval</category><category>regulatory affairs</category><category>NDA</category><category>BLA</category><category>pharmaceutical regulation</category><author>editors@progrna.com (ProgRNA Editorial Team)</author></item><item><title>High-Throughput Screening Techniques in Drug Discovery</title><link>https://progrna.com/blog/high-throughput-screening-techniques/</link><guid isPermaLink="true">https://progrna.com/blog/high-throughput-screening-techniques/</guid><description>Explore high-throughput screening techniques in drug discovery including compound libraries, automation, assay technologies, and the hit-to-lead optimization process.</description><pubDate>Sat, 11 Jul 2026 00:00:00 GMT</pubDate><category>tools</category><category>high-throughput screening</category><category>drug discovery</category><category>compound libraries</category><category>automation</category><category>hit-to-lead</category><author>editors@progrna.com (ProgRNA Editorial Team)</author></item><item><title>mRNA Technology in Vaccine Development: From Lab to Clinic</title><link>https://progrna.com/blog/mrna-technology-vaccine-development/</link><guid isPermaLink="true">https://progrna.com/blog/mrna-technology-vaccine-development/</guid><description>Discover how mRNA technology revolutionized vaccine development, from lipid nanoparticles to modified nucleosides, and its applications beyond COVID-19.</description><pubDate>Sat, 11 Jul 2026 00:00:00 GMT</pubDate><category>rna-therapeutics</category><category>mRNA technology</category><category>vaccine development</category><category>biotechnology</category><category>lipid nanoparticles</category><category>modified nucleosides</category><author>editors@progrna.com (ProgRNA Editorial Team)</author></item><item><title>Pharmacokinetics and Pharmacodynamics: The Basics Explained</title><link>https://progrna.com/blog/pharmacokinetics-pharmacodynamics-basics/</link><guid isPermaLink="true">https://progrna.com/blog/pharmacokinetics-pharmacodynamics-basics/</guid><description>Learn the fundamentals of pharmacokinetics and pharmacodynamics including ADME processes, half-life, bioavailability, dose-response curves, and therapeutic window.</description><pubDate>Sat, 11 Jul 2026 00:00:00 GMT</pubDate><category>tools</category><category>pharmacokinetics</category><category>pharmacodynamics</category><category>ADME</category><category>pharmacology</category><category>drug development</category><author>editors@progrna.com (ProgRNA Editorial Team)</author></item><item><title>Precision Medicine and Pharmacogenomics: Personalizing Drug Therapy</title><link>https://progrna.com/blog/precision-medicine-pharmacogenomics/</link><guid isPermaLink="true">https://progrna.com/blog/precision-medicine-pharmacogenomics/</guid><description>Discover how precision medicine and pharmacogenomics personalize drug therapy through CYP2D6/CYP2C19 polymorphisms, biomarker-guided treatment, and genetic testing.</description><pubDate>Sat, 11 Jul 2026 00:00:00 GMT</pubDate><category>ai-rna</category><category>precision medicine</category><category>pharmacogenomics</category><category>personalized medicine</category><category>biomarkers</category><category>drug therapy</category><author>editors@progrna.com (ProgRNA Editorial Team)</author></item><item><title>AI in RNA Research: Language Models for mRNA Design</title><link>https://progrna.com/blog/ai-mrna-language-models/</link><guid isPermaLink="true">https://progrna.com/blog/ai-mrna-language-models/</guid><description>How transformer-based language models are being applied to RNA sequence design, structure prediction, and therapeutic mRNA optimization — a survey for practitioners.</description><pubDate>Wed, 08 Jan 2025 00:00:00 GMT</pubDate><category>ai-rna</category><category>AI</category><category>Language Models</category><category>mRNA Design</category><category>RNA Structure</category><category>Transformers</category><author>editors@progrna.com (Dr. Sofía Álvarez)</author></item><item><title>R vs Python for Bioinformatics: Which to Learn</title><link>https://progrna.com/blog/r-vs-python-bioinformatics/</link><guid isPermaLink="true">https://progrna.com/blog/r-vs-python-bioinformatics/</guid><description>An honest comparison of R and Python for bioinformatics work — where each dominates, where they overlap, and a pragmatic recommendation for people starting out.</description><pubDate>Sat, 04 Jan 2025 00:00:00 GMT</pubDate><category>tools</category><category>R</category><category>Python</category><category>Bioconductor</category><category>scanpy</category><category>Tools</category><author>editors@progrna.com (Marcus Nkemdirim)</author></item><item><title>Circular RNA: The Next Frontier in RNA Medicine</title><link>https://progrna.com/blog/circular-rna-medicine/</link><guid isPermaLink="true">https://progrna.com/blog/circular-rna-medicine/</guid><description>How circular RNAs are made, why they&apos;re promising as therapeutics and vaccines, and the delivery and stability advantages driving a wave of clinical programs.</description><pubDate>Thu, 02 Jan 2025 00:00:00 GMT</pubDate><category>rna-therapeutics</category><category>circRNA</category><category>Circular RNA</category><category>IRES</category><category>Therapeutics</category><category>mRNA</category><author>editors@progrna.com (Nadia Farooq, MSc)</author></item><item><title>siRNA vs ASO: RNA Therapeutics Comparison</title><link>https://progrna.com/blog/sirna-vs-aso/</link><guid isPermaLink="true">https://progrna.com/blog/sirna-vs-aso/</guid><description>How siRNA and antisense oligonucleotides differ in mechanism, chemistry, delivery, and clinical scope — a practitioner&apos;s comparison of the two dominant oligonucleotide modalities.</description><pubDate>Fri, 27 Dec 2024 00:00:00 GMT</pubDate><category>rna-therapeutics</category><category>siRNA</category><category>ASO</category><category>RNAi</category><category>Antisense</category><category>Oligonucleotides</category><author>editors@progrna.com (Nadia Farooq, MSc)</author></item><item><title>Kallisto vs Salmon: Pseudo-Alignment Tools Compared</title><link>https://progrna.com/blog/kallisto-vs-salmon/</link><guid isPermaLink="true">https://progrna.com/blog/kallisto-vs-salmon/</guid><description>Two flagship pseudo-alignment quantifiers for RNA-Seq compared on speed, accuracy, and the small but meaningful differences that matter downstream.</description><pubDate>Fri, 20 Dec 2024 00:00:00 GMT</pubDate><category>rna-seq</category><category>Salmon</category><category>Kallisto</category><category>Pseudo-alignment</category><category>Quantification</category><category>tximport</category><author>editors@progrna.com (Marcus Nkemdirim)</author></item><item><title>Single-Cell RNA-Seq Analysis: Complete Workflow with Seurat</title><link>https://progrna.com/blog/scrna-seq-seurat-workflow/</link><guid isPermaLink="true">https://progrna.com/blog/scrna-seq-seurat-workflow/</guid><description>A concise Seurat v5 workflow for droplet single-cell RNA-Seq — QC, normalization, integration, clustering, and marker discovery — with the flags that matter.</description><pubDate>Mon, 16 Dec 2024 00:00:00 GMT</pubDate><category>rna-seq</category><category>scRNA-Seq</category><category>Seurat</category><category>Single-Cell</category><category>R</category><category>Integration</category><author>editors@progrna.com (Dr. Lin Wei)</author></item><item><title>Python for Bioinformatics: Essential Libraries and Tools</title><link>https://progrna.com/blog/python-bioinformatics/</link><guid isPermaLink="true">https://progrna.com/blog/python-bioinformatics/</guid><description>The Python stack that actually gets used in production bioinformatics — Biopython, pysam, pandas, scanpy, snakemake, and the environments and tooling that hold it all together.</description><pubDate>Thu, 12 Dec 2024 00:00:00 GMT</pubDate><category>tools</category><category>Python</category><category>Biopython</category><category>pysam</category><category>pandas</category><category>scanpy</category><category>Snakemake</category><author>editors@progrna.com (Marcus Nkemdirim)</author></item><item><title>RNA Interference (RNAi) Mechanism and Therapeutic Applications</title><link>https://progrna.com/blog/rnai-mechanism/</link><guid isPermaLink="true">https://progrna.com/blog/rnai-mechanism/</guid><description>How endogenous RNAi and engineered siRNA silence gene expression — the Argonaute/RISC machinery, GalNAc delivery, and the growing list of approved siRNA drugs.</description><pubDate>Thu, 05 Dec 2024 00:00:00 GMT</pubDate><category>rna-therapeutics</category><category>RNAi</category><category>siRNA</category><category>Argonaute</category><category>GalNAc</category><category>Therapeutics</category><author>editors@progrna.com (Nadia Farooq, MSc)</author></item><item><title>mRNA Vaccine Technology: How It Works and Future Applications</title><link>https://progrna.com/blog/mrna-vaccine-technology/</link><guid isPermaLink="true">https://progrna.com/blog/mrna-vaccine-technology/</guid><description>A grounded technical explainer on mRNA vaccine architecture — modified nucleosides, lipid nanoparticle delivery, immunogenicity, and where the field is headed after COVID-19.</description><pubDate>Thu, 28 Nov 2024 00:00:00 GMT</pubDate><category>rna-therapeutics</category><category>mRNA</category><category>Vaccines</category><category>LNP</category><category>Pseudouridine</category><category>Therapeutics</category><author>editors@progrna.com (Nadia Farooq, MSc)</author></item><item><title>STAR vs HISAT2: RNA-Seq Aligner Comparison</title><link>https://progrna.com/blog/star-vs-hisat2/</link><guid isPermaLink="true">https://progrna.com/blog/star-vs-hisat2/</guid><description>A practical, benchmark-informed comparison of STAR and HISAT2 for short-read RNA-Seq alignment — accuracy, memory, speed, splice discovery, and when to prefer each.</description><pubDate>Wed, 20 Nov 2024 00:00:00 GMT</pubDate><category>rna-seq</category><category>STAR</category><category>HISAT2</category><category>Alignment</category><category>RNA-Seq</category><category>Benchmark</category><author>editors@progrna.com (Marcus Nkemdirim)</author></item><item><title>How to Use DESeq2 for Differential Expression Analysis</title><link>https://progrna.com/blog/deseq2-differential-expression/</link><guid isPermaLink="true">https://progrna.com/blog/deseq2-differential-expression/</guid><description>A rigorous walkthrough of the DESeq2 workflow: count matrix prep, dispersion estimation, LFC shrinkage, batch correction, and pitfalls that get past most tutorials.</description><pubDate>Tue, 12 Nov 2024 00:00:00 GMT</pubDate><category>rna-seq</category><category>DESeq2</category><category>Differential Expression</category><category>R</category><category>Bioconductor</category><category>RNA-Seq</category><author>editors@progrna.com (Dr. Lin Wei)</author></item><item><title>RNA-Seq Data Analysis: Complete Step-by-Step Guide for Beginners</title><link>https://progrna.com/blog/rna-seq-complete-guide/</link><guid isPermaLink="true">https://progrna.com/blog/rna-seq-complete-guide/</guid><description>A hands-on, reproducible guide to a modern bulk RNA-Seq pipeline — from raw FASTQ files through QC, trimming, alignment, quantification, and differential expression.</description><pubDate>Tue, 05 Nov 2024 00:00:00 GMT</pubDate><category>rna-seq</category><category>RNA-Seq</category><category>Bioinformatics</category><category>FASTQ</category><category>STAR</category><category>featureCounts</category><category>DESeq2</category><author>editors@progrna.com (Dr. Lin Wei)</author></item></channel></rss>